Belite Bio Inc ADR(BLTE)— 技术面状态
数据截至2026-10-30 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -4.2% vs the 50-day and -3.5% vs the 200-day average, 22.6% below the 52-week high and +62.4% off the 52-week low; a golden cross printed 40 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+2.1%
- 相对50日均线-4.2%
- 相对200日均线-3.5%
- 52周区间低于52周高点22.6% · 高于52周低点62.4%
- 连续走势连续4个交易日上涨
- 均线交叉金叉(40个交易日前)
- 50日均线交叉股价向下穿越50日均线(21个交易日前)
- 随机指标%K 67.7 · %D 34.2
FAQ · from the current data · as of 2026-10-30
Quick answers
BLTE当前的Closelook信号是什么?
Mixed moving-average stack — Trades -4.2% vs the 50-day and -3.5% vs the 200-day average, 22.6% below the 52-week high and +62.4% off the 52-week low; a golden cross printed 40 sessions ago. Computed from daily closes.(截至2026-10-30;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
BLTE目前是否位于50日和200日均线上方?
截至2026-10-30,Belite Bio Inc ADR位于50日均线下方(-4.2%),200日均线下方(-3.5%);距20日均线+2.1%。
BLTE距52周高点有多远?
截至2026-10-30,低于52周高点22.6%,高于52周低点62.4%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry